Evening primrose (Oenothera biennis)

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 197-210

  Shahidi, Fereidoon ^a   Miraliakbari, Homan ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959697945     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022103     Document Type: Chapter

References (96)

1. Novak, F.A. The Pictorial Encyclopedia of Plants and Flowers; Crown Publishers Incorporated: New York, 1966.
2. Horner, N.K.; Lampe, J.W. Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness. J. Am. Diet. Assoc. 2000, 100, 1368–1380.
3. Kleijnen, J., Evening primrose oil. Br. Med. J. 1994, 309, 824–825.
4. Barre, D.E., Potential of evening primrose, borage, blackcurrant and fungal oils in human health. Ann. Nutr. Metab 2001, 45, 47–57.
5. US Food and Drug Administration Center for Food Safety and Applied Nutritional Health Claims. Available at: http://vm.cfsan.fda.gov/_dms/flg-6c.html.
6. Abeywardena, M.Y.; Jablonskis, L.T.; Head, R.J. Dietary n-3 and n-6 polyunsaturated oils and airway contractility. Prostaglandins Leukot. Essent. Fatty Acids 2001, 6, 281–287.
7. Sanders, T.A.B., Essential fatty acid requirements of vegetarians in pregnancy, lactation, and infancy. Am. J. Clin. Nutr 1999, 70, 555S–559S.
8. Assies, J.; Lieverse, R.; Vreken, P.; Wanders, R.J.A.; Dingemans, P.; Linszen, D.H., Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol. Psychiatry 2001, 49, 510–522.
9. Brenna, J.T., Efficiency of conversion of alphalinolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5, 127–132.
10. Smith, C.J.; Zhang, Y.; Koboldt, C.M.; Muhammad, J.; Zweifel, B.S.; Shaffer, A.; Talley, J.J.; Masferrer, J.L.; Seibert, K.; Isakson, P.C. Pharmacological analysis of cyclooxygenase in inflammation. Proc. Natl. Acad. Sci 1998, 95, 13,313–13.
11. Eberhart, C.E.; Coffey, R.J.; Radhika, A.; Giardiello, F.M.; Ferrenbach, S.; Dubois, R.N. Up-regulation of cyclooxygenase-II gene expression in human colo-rectal adenomas and adenocarcinomas. Gastroenterology 1994, 107, 1183–1188.
12. Mclennan, P.; Howe, P.; Abeywardena, M.; Muggli, R.; Raederstorff, D.; Mano, M.; Rayner, T.; Head, R. The cardiovascular protective role of docosapentaenoic acid. Eur. J. Pharmacol. 1996, 300, 83–89.
13. Johnson, M.M.; Swan, D.D.; Surette, M.E.; Stegner, J.; Chilton, T.; Fontech, A.N.; Chilton, F.H. Dietary supplementation with g-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J. Nutr. 1997, 127, 1435–1444.
14. Kunkel, S.L.; Ogawa, H.; Conran, P.B.; Ward, P.A.; Zurier, R.B. Suppression of chronic inflammation by evening primrose oil. Prog. Lipid Res. 1981, 20, 886–888.
15. Miller, C.C.; McCreedy, C.A.; Jones, A.D.; Ziboh, V.A. Oxidative metabolism of dihomo-glinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products. Prostaglandins 1988, 35, 917–938.
16. Cia, J.; Jiang, W.G.; Mansel, R.E. Inhibition of angiogenic factor- and tumor-induced angiogenesis by g-linolenic acid. Prostaglandins Leukot. Essent. Fatty Acids 1999, 60, 21–29.
17. James, M.J.; Gibson, R.A.; Cleland, L.G., Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr 2000, 71, 343S–348S.
18. Sirtori, C.R.; Galli, C., N-3 fatty acids and diabetes. Biomed. Pharmacother. 2002, 56, 397–406.
19. Wertz, P.W.; Swartzendruber, D.C.; Abraham, W.; Madison, K.C.; Downing, D.T., Essential fatty acids and epidermal integrity. Arch. Dermatol 1987, 123, 1381–1384.
20. Simopoulos, A.P.; Koletzko, B.; Anderson, R.E.; Hornstra, G.; Mensink, R.P.; Weksler, B.B.; Harris, W.S.; De Caterina, R.; Muggli, R.; Spercher, H. The 1st Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL): fatty acids and lipids from cell biology to human disease. J. Lipid Res. 1994, 35, 169–173.
21. Hibbeln, J.R.; Salem, N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am. J. Clin. Nutr. 1995, 62, 1–9.
22. Clarke, S.D.; Jump, D.B. Regulation of gene expression by dietary fat. Ann. Nutr. 1999, 19, 63–90.
23. Schalin-Karrila, M.; Matila, L.; Jansen, C.T.; Utila, P. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br. J. Dermatol. 1987, 117, 11–19.
24. Horrobin, D.F., Nutritional and medicinal importance of gamma-linolenic acid. J. Lipid Res. 1992, 31, 163–166.
25. De La Puerta-Vazquez, R.; Martinez-Dominguez, E.; Sanchez-Perona, J.; Ruiz-Gutierrez, V. Effects of different oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. Metabolism 2004, 53, 59–65.
26. Hanifin, J.M.; Rajka, G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. 1980, 92, 44–47.
27. Charman, C.R.; Morris, A.D.; Williams, H.C. Topical corticosteroid phobia in patients with atopic eczema. Br. J. Dermatol 2000, 142, 931–936.
28. Lovell, C.R.; Burton, J.L.; Horrobin, D.F. Treatment of atopic eczema with evening primrose oil. Lancet 1981, 1, 287 29.
29. Manku, M.S.; Horrobin, D.F.; Morse, N.; Kyte, V.; Jenkins, K.; Wright, S.; Burton, J.L. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot. Med 1984, 9, 615–628.
30. Morse, P.F.; Horrobin, D.F.; Manku, M.S.; Stewart, J.C.; Allen, R.; Littlewood, S.; Wright, S.; Burton, J.; Gould, J.; Holt, P.J., Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br. J. Dermatol 1989, 121, 75–90.
31. Bamford, J.T.; Gibson, R.W.; Renier, C.M. Atopic eczema unresponsive to evening primrose oil. J. Am. Acad. Dermatol. 1985, 3, 959–965.
32. Hederos, C.A.; Berg, A., Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch. Dis. Child 1996, 75, 494–497.
33. Berth-Jones, J.; Graham-Brown, R.A.C. Placebocontrolled study of essential fatty acid supplementation in atopic dermatitis. Lancet 1993, 341, 1557–1560.
34. Kerscher, M.J.; Korting, H.C., Treatment of atopic eczema with evening primrose oil: rational and clinical results. Clin. Invest 1992, 70, 167–171.
35. Yoon, S.; Lee, J.; Lee, S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol. Appl. Skin Physiol 2002, 15, 20–25.
36. Lee, S.H.; Lee, J.H.; Lee, S.C.; Kim, K.X. Interleukin-4 as a new index of disease severity in atopic dermatitis. Kor. J. Dermatol 1998, 36, 95–102.
37. Williams, H.C., Evening primrose oil for atopic dermatitis. Br. Med. J 2003, 327, 1358–1359.
38. Granlund, H., Treatment of childhood eczema. Paediatr. Drugs 2002, 4, 729–735.
39. Belch, J.J.F.; Hill, H., Evening primrose oil and borage oil in rheumatologic conditions. Am. J. Clin. Nutr 2000, 71, 352S–356S.
40. Lau, C.; O’Dowd, A.; Belch, J.J.F.White cell activation in the Raynaud’s phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann. Rheum. Dis 1992, 51, 249–252.
41. Horrobin, D.F., Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and Sjogren’s syndrome. Med. Hypothesis 1984, 14, 233–247.
42. Martens_Lobenhoffer, J.; Meyer, F.P. Pharmacokinetic data of gamma-linolenic acid in healthy volunteers after the administration of evening primrose oil. Int. J. Clin. Pharmacol. Ther. 1998, 36, 363–366.
43. Brown, J.; Sim, A.K.; De Ceular, K.; McLeod, M.; El-Ghorbarey, F.; Dick, W.C. Naudicelle in patients with rheumatoid arthritis. Therapeutique 1980, 50, 355–357.
44. Hansen, T.M.; Lershe, A.; Kassis, V.; Lorenzen, I.; Sondergaard, J., Treatment of rheumatoid arthritis with prostaglandin E1 precursors cislinoleic acid and gamma-linolenic acid. Scand. J. Rheumatol 1983, 12, 85–88.
45. Jantti, J.; Seppala, E.; Vapaatalo, H.; Isomaki, H., Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin. Rheumatol 1989, 8, 238–244.
46. Brzeski, M.; Madhok, R.; Capel, H.A., Evening primrose oil in patients with rheumatoid arthritis and side effects of non steroidal anti-inflammatory drugs. Br. J. Rheumatol 1991, 30, 370–372.
47. Belch, J.J.F.; Ansell, D.; Madhok, R.; O’Dowd, A.; Sturrok, R.D. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in rheumatoid arthritis: a double blind placebo controlled study. Ann. Rheum. Dis. 1988, 47, 96–104.
48. Darlington, L.G.; Stone, T.W. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br. J. Nutr. 2001, 85, 251–269.
49. de Lorgeril, M.; Salen, P.; Laporte, F.; de Leiris, J., Alpha-linolenic acid in the prevention and treatment of coronary heart disease. Eur. Heart J 2002, 3, D26–D32.
50. Dolocek, T.A.; Granditis, G., Dietary polyunsaturated fatty acids and mortality in multiple risk factor intervention trial (MRFIT). World Rev. Nutr. Diet 1991, 66, 205–216.
51. Calder, P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36, 1007–1024.
52. Tapiero, H.; Nguyen Ba, G.; Couvreur, P.; Tew, K.D., Polyunsaturated fatty acids (PUFA) and eicosanoids in human health pathologies. Biomed. Pharmacother 2002, 56, 215–222.
53. Oomah, B.D.; Mazza, G. Health benefits of phytochemicals from selected Canadian crops. Trends Food Sci. Technol 1999, 10, 193–198.
54. Coker, S.J.; Parratt, J.R. AH23848, a thromboxane antagonist, suppresses ischemia and reperfusion induced in anaesthetized greyhounds. Br. J. Pharmacol. 1985, 86, 259–264.
55. Singer, P.; Moritz, V.; Wirth, M.; Berger, I.; Forster, D., Blood pressure and serum lipids from SHR after diets supplemented with evening primrose, sunflower or fish oil. Prostaglandins Leukot. Essent. Fatty Acids 1990, 40, 17–20.
56. Singer, P.; Berger, I.; Moritz, V.; Forster, D.; Taube, C. N-6 and N-3 PUFA in liver lipids, thromboxane formation and blood pressure from SHR during diets supplemented with evening primrose, sunflower seed or fish oil. Prostaglandins Leukot.Essent. Fatty Acids 1990, 39, 207–211.
57. Horrobin, D.F. Omega-6 and omega-3 essential fatty acids in atherosclerosis. Semin. Thromb. Hemost 1993, 19, 129–137.
58. De la Cruz, J.P.; Martin-Romero, M.; Carmona, J.A.; Villabos, M.A.; Sanchez de la Cuesta, F. Effect of evening primrose oil on platelet aggregation in rabbits fed an atherogenic diet. Thromb. Res 1997, 87, 141–149.
59. De la Cruz, J.P.; Quintero, L.; Galvez, J.; Villalobos, M.A.; Sanchez de la Cuesta, F. Antioxidant potential of evening primrose oil administration in hyperlipidemic rabbits. Life Sci. 1999, 65, 543–555.
60. Charnock, J.S. Gamma-linolenic acid provides additional protection against ventricular fibrillation in aged rats fed linoleic acid rich diets. Prostaglandins Leukot. Essent. Fatty Acids 2000, 62, 129–134.
61. Abraham, R.D.; Riemsrsma, R.A.; Elton, R.A.; Macintyre, C.; Oliver, M.F. Effect of safflower oil and evening primrose oil in men with a low dihomo-gamma-linolenic level. Atherosclerosis 1990, 81, 199–208.
62. Khan, F.; Elherik, K.; Bolton-Smith, C.; Barr, R.; Hill, A.; Murrie, I.; Belch, J.J.F. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc. Res. 2003, 59, 955–962.
63. Hale, A.J.; Smith, A.C.; Sutherland, L.C.; Stoneman, V.E.A.; Longthorne, V.L.; Culhane, A.C.; Williams, G.T. Apoptosis: molecular recognition of death. Eur. J. Biochem. 1996, 236, 1–26.
64. Prener, A.; Storm, H.H.; Nielsen, N.H. Cancer of the male genital tract in circumpolar Inuit. Acta Oncol. 1996, 35, 589–593.
65. Booyens, J.; Engelbrecht, P.; le-Roux, S.; Louwrens, C.C.; Van der Merwe, C.F.; Katzeff, I.E. Some effects of the essential fatty acids linoleic acid, alpha-linolenic acid and their metabolites gamma-linolenic acid arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid and of prostaglandins A1 and E1 on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukot. Med. 1984, 15, 15–33.
66. Gardiner, N.S.; Duncan, J.R. Possible involvement of a delta-6 desaturase in control of melanoma growth by gamma-linolenic acid. Prostaglandins Leukot. Med. 1991, 42, 149–153.
67. Ramesh, G.; Das, U.N., Effect of evening primrose oil and fish oils on two stage skin carcinogenesis in mice. Prostaglandins Leukot. Essent. Fatty Acids 1998, 59, 155–161.
68. Kollias, J.; Macmillan, D.M.; Sibbering, D.M.; Berrel, H.; Robertson, J.F.R. Effect of evening primrose oil on clinically diagnosed fibroadenomas. Breast 2000, 9, 35–36.
69. Dove, D.; Johnson, P. Oral evening primrose oil: its effects on length of pregnancy and selected intrapartum outcomes in low nulliparous women. J. Nurse-Midwifery 1999, 44, 320–324.
70. Erlik, Y.; Meldrum, D.R.; Judd, H.L. Estrogen levels in postmenopausal women with hot flashes. Obstet. Gynecol. 1982, 59, 403–411.
71. Glazier, M.G.; Bowman, M.A., A review of evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Int. Med 2001, 161, 11,161–11.
72. Chenoy, R.; Hussain, S.; Tayob, Y.; O’Brean, P.M.S.; Moss, M.Y.; Morse, P.F. Effect of oral gamma-linolenic acid from evening primrose oil on menopausal flushing. Br. Med. J. 1994, 308, 501–503.
73. Bassey, E.J.; Littlewood, J.J.; Rothwell, M.C.; Pye, D.W. Lack of effect of supplementation with essential fatty acids on bone mineral density in pre- and postmenopausal women: two randomized controlled trials of Efacal_ v. calcium alone. Br. J. Nutr. 2000, 83, 629–635.
74. Blommers, J.; de Lange de Cleric, E.; Kuik, D.J.; Bezemer, P.D.; Meiger, S., Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. Am. J. Obstet. Gynecol 2002, 187, 1389–1394.
75. Campbell, E.M.; Peterkin, K.; O’Grady, R.; Sanson-Fisher, R. Premenstrual symptoms in general practice. J. Reprod. Med. 1997, 42, 637–646.
76. Chan, S.; Hanifin, J. Immunopharmacologic aspects of atopic dermatitis. Clin. Rev. Allergy 1993, 11, 523–541.
77. Be Lieu, R.M., Mastodynia. Obstet. Gynecol. Clin. North Am. 1994, 21, 461–477.
78. Khoo, S.K.; Munro, C.; Battistutta, D., Evening primrose oil and treatment of premenstrual syndrome. Med. J. Aust 1990, 153, 189–192.
79. Budeiri, D.; Li-Wan-Po, A.; Dornan, J.C. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control. Clin. Trials 1996, 17, 60–68.
80. Bang, H.O.; Dyerberg, J., Lipid metabolism and ischemic heart disease in Greenland Eskimos. Adv. Nutr. Res 1980, 3, 1–22.
81. Zielinski, M.; Wojnarski, L.; Celewicz, Z.; Cretti, A. Influence of evening primrose oil on blood pressure and the pressor response to angiotensin II in pregnant and non-pregnant rabbits. Ginekol. Pol. 1994, 65, 111–114.
82. Moodley, J.; Norman, R.J. Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia. Prostaglandins Leukot. Essent. Fatty Acids 1989, 37, 145–147.
83. D’Almeida, A.; Carter, J.P.; Anatol, A.; Prost, C. Effects of combination of evening primrose oil (gammalinolenic acid) and fish oil (eicosapentaenoic þ docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992, 19, 117–131.
84. Storlein, L.H.; Pan, D.A.; Kriketos, J.; O’Conner, I.D.; Caterson, G.J.; Clooney, A.B.; Jenkins, J.; Baur, L.A. Skeletal muscle lipid membranes and insulin resistance. Lipids 1996, 31, S262–S265.
85. Cameron, N.E.; Cotter, M.A. The relationship of vascular changes to metabolic functions in diabetes mellitus and their role in the development of peripheral nerve complications. Diab. Metab. Rev. 1994, 10, 189–224.
86. Dutta-Roy, A.K. Insulin mediated processes and in platelets, erythrocytes and monocytes= macrophages: effects of essential fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 1994, 51, 385–399.
87. Cameron, N.E.; Cotter, M.A.; Dines, K.C.; Robertson, S.; Cox, D. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclooxygenase inhibitor flubiprofen. Br. J. Pharmacol. 1993, 109, 972–979.
88. Dines, K.C.; Cameron, N.E.; Cotter, M.A. Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats. J. Pharmacol. Exp. Ther. 1995, 273, 49–55.
89. Ford, I.; Cotter, M.A.; Cameron, N.E.; Greaves, M. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 2001, 50, 868–875.
90. Joy, C.B.; Mumby-Croft, R.; Joy, L.A. Polyunsaturated fatty acid (fish or evening primrose) for schizophrenia. Cochrane Database Syst. Rev. 2000, 2, 1257.
91. Endres, S.; Lorenz, R.; Loeschke, K. Lipid treatment of inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 1999, 2, 117–129.
92. Morphake, P.; Bariety, J.; Darlamastos, I.; Tsipas, G.; Gkkias, G.; Hornysh, A.; Papanikolaou, N. Alteration of cyclosporine (CsA)- induced nephrotoxicity by gamma linolenic acid (GLA) and eicosapentaenoic acid (EPA) in Wistar rats. Prostaglandins Leukot. Essent. Fatty Acids 1994, 50, 29–35.
93. Greenfield, S.M.; Green, A.T.; Teare, J.P.; Jenkins, A.P.; Punchaurd, N.A.; Ainely, C.C.; Thompson, R.P. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment. Pharmacol. Ther 1993, 7, 159–166.
94. Darlametsos, I.E.; Varonos, D.D., Role of prosanoids and endothelins in the prevention of cyclosporine- induced nephrotoxicity. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64, 231–239.
95. Scholey, J.W.; Mills, D.E. Dietary fatty acids and the glomerular hemodynamic response to cyclosporine in borderline hypertensive rats. Kidney Int. 1995, 47, 611–617.
96. Yoshimoto-Furuie, K.; Yoshimoto, K.; Tanaka, T.; Saima, S.; Kikuchi, Y.; Shay, J.; Horrobin, D.F.; Echizen, H. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron 1999, 81, 151–159.